Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Audentes Therapeutics, Inc. (BOLD)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/31/2022 |
3
| Audentes Therapeutics, Inc. (10% Owner) has filed a Form 3 on Taysha Gene Therapies, Inc. |
| 07/17/2019 |
3
| Conner Edward R. (SVP, Chief Medical Officer) has filed a Form 3 on Audentes Therapeutics, Inc. |
| 04/01/2019 |
3
| Meltz Mark A (SVP, General Counsel) has filed a Form 3 on Audentes Therapeutics, Inc. |
| 01/04/2019 |
3
| Mosbrooker Eric (SVP, Chief Commercial Officer) has filed a Form 3 on Audentes Therapeutics, Inc. |
| 12/13/2017 |
3
| Goldberg Mark Alan (Director) has filed a Form 3 on Audentes Therapeutics, Inc. |
| 06/13/2017 |
3
| Jarrett Jennifer (Director) has filed a Form 3 on Audentes Therapeutics, Inc. |
| 12/13/2016 |
3
| Smith Julie (Director) has filed a Form 3 on Audentes Therapeutics, Inc. |
| 07/19/2016 |
3
| Woiwode Thomas (Director) has filed a Form 3 on Audentes Therapeutics, Inc. |
| 07/19/2016 |
3
| Versant Ventures IV, LLC (10% Owner) has filed a Form 3 on Audentes Therapeutics, Inc. |
| 07/19/2016 |
3
| SQUINTO STEPHEN P (Director) has filed a Form 3 on Audentes Therapeutics, Inc. |
| 07/19/2016 |
3
| Flynn James E (10% Owner) has filed a Form 3 on Audentes Therapeutics, Inc. |
| 07/19/2016 |
3
| Soloway Thomas P (Senior Vice President, CFO) has filed a Form 3 on Audentes Therapeutics, Inc. |
| 07/19/2016 |
3
| SILVERSTEIN JONATHAN (10% Owner) has filed a Form 3 on Audentes Therapeutics, Inc. |
| 07/19/2016 |
3
| PRASAD SUYASH (Senior VP & Chief Med Officer) has filed a Form 3 on Audentes Therapeutics, Inc. |
| 07/19/2016 |
3
| Patterson Matthew R (President & CEO) has filed a Form 3 on Audentes Therapeutics, Inc. |
| 07/19/2016 |
3
| PARMAR KUSH (Director) has filed a Form 3 on Audentes Therapeutics, Inc. |
| 07/19/2016 |
3
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 3 on Audentes Therapeutics, Inc. |
| 07/19/2016 |
3
| NEWMAN MARY (SVP, Regulatory Affairs) has filed a Form 3 on Audentes Therapeutics, Inc. |
| 07/19/2016 |
3
| Nagler David (SVP, HR & Corp. Affairs) has filed a Form 3 on Audentes Therapeutics, Inc. |
| 07/19/2016 |
3
| Morrison Scott W (Director) has filed a Form 3 on Audentes Therapeutics, Inc. |
| 07/19/2016 |
3
| Holles Natalie C. (Senior Vice President, COO) has filed a Form 3 on Audentes Therapeutics, Inc. |
| 07/19/2016 |
3
| GRAY JOHN T. (Senior Vice President, R & D) has filed a Form 3 on Audentes Therapeutics, Inc. |
| 07/19/2016 |
3
| 5AM Partners III, LLC (10% Owner) has filed a Form 3 on Audentes Therapeutics, Inc. |
|
|